Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Editorial] Brexit’s effect on access to new medicines

The latest warning of the negative outcomes of Brexit on the UK’s life sciences sector (medicines, therapies, and biotechnologies) came from a report published last week by the UK think tank, Public Policy Projects. The report highlights the challenges from a regulatory, funding, and patient access to new medicines perspective under different Brexit scenarios.